Acute airway obstruction in cervical spinal procedures with bone morphogenetic proteins

Laryngoscope

Volumn 120, Issue 10, 2010, Pages 1954-1957

  Yaremchuk, Kathleen L ^a   Toma, Mark S ^b,c   Somers, Melissa L ^a   Peterson, Ed ^b  

^a HENRY FORD HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Airway obstruction; Bone morphogenetic protein (BMP); Cervical spinal procedure; Off label use

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ACUTE AIRWAY OBSTRUCTION; AIRWAY OBSTRUCTION; ANTERIOR SPINE FUSION; ARTICLE; CERVICAL SPINE; CONTROLLED STUDY; DYSPHAGIA; DYSPHASIA; DYSPNEA; HOARSENESS; HOSPITAL CHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; INTUBATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; TRACHEOTOMY;

ACUTE DISEASE; AIRWAY OBSTRUCTION; APHASIA; BONE MORPHOGENETIC PROTEINS; CERVICAL VERTEBRAE; DEGLUTITION DISORDERS; DYSPNEA; FEMALE; GASTROSTOMY; HOARSENESS; HOSPITAL CHARGES; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; PATIENT READMISSION; PROPORTIONAL HAZARDS MODELS; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; SPINAL DISEASES; SPINAL FUSION; SURVIVAL RATE; TRACHEOTOMY; TREATMENT OUTCOME;

EID: 78649838946     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.21096     Document Type: Article

References (11)

1. Lad SP, Patil CG, Berta S, et al. National trends in spinal fusion for cervical spondylotic myelopathy. Surg Neurol 2009;71:66-69.
2. McKay WF, Peckham SM, Badura JM. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSEVR bone graft). Int Orthopaed 2007;31:729-734.
3. Garrison KR, Donell S, Ryder J, et al. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: A systematic review. Health Technol Assess 2007;11:1-150.
4. Crawford CH, Carreon LY, McGinnis MD, et al. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis. Spine 2009;34:1390-1394.
5. Cahill KS, Chi JH, Day A, et al. Prevalence, complications, and hospital charges associated with the use of bone-morphogenetic proteins in spinal fusion procedures. JAMA 2009;302:58-66.
6. Smucker JD, Rhee JM, Singh K, et al. Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine. Spine 2006;31:2813-2819.
7. Perri B, Cooper M, Lauryssen C, et al. Adverse swelling associated with the use of rh-BMP-2 in anterior cervical discectomy and fusion: A case study. Spine J 2007;7: 235-239.
8. US Food and Drug Administration Public Health Notification. Life-threatening complications associated with recombinant human bone morphogenetic protein in cervical spine fusion. July 1, 2008. Available at: Http://www. fda.gove/cdrf/safety/070108-rhbmp.html.
9. SAS Institute Inc. SAS/STAT 9.1 User's Guide. Cary NC: SAS Institute Inc.; 2004.
10. Boakye M, Patil CG, Santarelli J, et al. Cervical spondylotic myelopathy: Complications and outcomes after spinal fusion. Neurosurgery 2008;62:455-462.
11. Lad SP, Patil CG, Berta S, et al. National trends in spinal fusion for cervical spondylotic myelopathy. Surg Neurol 2009;71:66-69.